Our consultancy provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices
Development
Medical product development is a complex, expensive, risky venture. How does one get from early findings to an approved product? How do you get to the key milestones as rapidly and efficiently as possible?
Gary Novack, Ph.D.
Gary D. Novack, Ph.D., President of PharmaLogic Development, Inc. has decades of experience in successful product development. Together with his team of senior experts, PharmaLogic can help you execute that plan.
Expertise
In our 25+ years working in manifold therapeutic areas with pharmaceuticals, biologics and devices, the firm’s particular expertise is in local therapy (ophthalmology and dermatology).
Based upon decades of successful product development experience, PharmaLogic Development, Inc., can help you develop and execute a strategic plan for your product. Working in manifold therapeutic areas with pharmaceuticals, biologics and devices, our expertise is in local therapy (ophthalmology and dermatology).
Dr. Novack states “The more I work in the development of new pharmaceuticals, the more I see that early development is a complex interaction of pharmaceutics (formulation), safety assessment (local and systemic), and clinical planning. Not only do we help plan and execute what needs to be done, but what needs to be done when.”
Many of his experiences and unique perspectives in product development may be found in the over two dozen editorials he has written as a contributing editor to The Ocular Surface.
Sonoma Eye 2018 – Foster Ophthalmic Immunology Society
Dr. Novack presented two oral papers at Sonoma Eye 2018, the second annual event held by the Foster Ophthalmic Immunology Society. One invited presentation was a brief summary of his 30-year perspective on how to evaluate a potential new therapy. The other dealt...
read moreUC Davis Library Leadership Board
I am proud to be a member of the University of California, Davis, Library Leadership Board. The Library Leadership Board plays an essential role in sustaining and enhancing the excellence of the UC Davis Library by advancing the library’s philanthropic goals and...
read moreFDA Commissioner cites “Kabuki drug-pricing constraints”
In a conference by a leading U.S. health insurer lobbying group (America's Health Insurance Plans, AHIP), US FDA Commissioner Scott Gottlieb, M.D. criticized "Kabuki drug-pricing constructs" that profit industry at the expense of consumers. He stated "Patients...
read more